BIONPHARMA INC FDA Approval ANDA 208819

ANDA 208819

BIONPHARMA INC

FDA Drug Application

Application #208819

Documents

Letter2018-11-15

Application Sponsors

ANDA 208819BIONPHARMA INC

Marketing Status

Prescription001

Application Products

001SUSPENSION;ORAL2.5MG/ML0CLOBAZAMCLOBAZAM

FDA Submissions

UNKNOWN; ORIG1AP2018-10-22STANDARD
LABELING; LabelingSUPPL5AP2021-11-12STANDARD

Submissions Property Types

ORIG1Null7
SUPPL5Null15

TE Codes

001PrescriptionAB

CDER Filings

BIONPHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208819
            [companyName] => BIONPHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CLOBAZAM","activeIngredients":"CLOBAZAM","strength":"2.5MG\/ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/22\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/208819Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-10-22
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.